1 Artificial intelligence (AI) Stock Down 80% to Buy Hand Over Fist for 2024
This growth stock uses artificial intelligence to recommend more engaging content.
Mindfully Curated
This growth stock uses artificial intelligence to recommend more engaging content.
This dividend stock could offer excellent returns for passive income investors in 2024 and beyond.
This dividend stock could offer excellent returns for passive income investors in 2024 and beyond.
A new study indicates that severity of amyloid deposition in the brain — not just age — may be key to determining who will benefit from new therapies that delay the progression of Alzheimer’s disease.
The program just plain isn’t running out of money.
Volatility should be the expectation. These two stocks can make money either way.
Here’s how to get nearly $24,000 in additional inflation-protected retirement income — every year.
Carnival delivered a strong fourth quarter and robust guidance. But given its massive debt load, is it a buy?
Make sure that your retirement plan can still thrive in a changing economic world.
A focus on its core business sets the company up for years of profitable growth.
Polygon, XRP, and Cardano all trade for less than $1. But are they worth buying?
These dividend stocks could make 2024 a truly happy new year for income investors.
There are good reasons to think these Berkshire Hathaway portfolio holdings will perform well in the new year.
Past precedents bode well for stocks next year. But there’s no guarantee that history will repeat itself.
Many companies will profit from the recent demand for artificial intelligence, but this one is a clear standout.
It always makes sense to have a wish list of companies you’d like to own — if the market offered them to you at the right price.
AI captured the spotlight in 2023, but don’t be surprised if other trends pop up on Wall Street’s radar in 2024.
It’s great to see your portfolio’s value go up, but it’s also important to take things in stride.
One of these small-cap ETFs stands out from the crowd.
Is Pfizer stock a bargain buy?